Clinical Trials
All Clinical Trials - Page 21 of 75
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT07644897Phase 2Recruiting
Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced Melanoma
Thymosin-Alpha-1
- NCT05866029N/ARecruiting
Study of the Key Techniques of Prevention and Treatment of Osteoporotic Refracture
Teriparatide
- NCT05965167Phase 1Completed
Assess Safety and Compare PK of New Oral hPTH(1-34) Tablet Formulations vs. EBP05 Tablets and Subcutaneous Forteo
Teriparatide
- NCT05793450Phase 1Completed
Pharmacokinetics of IBI362 in Subjects With and Without Renal Impairment
Mazdutide
- NCT06475586Phase 4Completed
Effect of Semaglutide on the Psoriatic Lesions in Patients With Type 2 Diabetes Mellitus
Semaglutide
- NCT05832060N/AUnknown
Comparing the Efficacy of tDCS and tRNS to Improve Reading Skills in Children and Adolescents With Dyslexia
Selank
- NCT05681299Phase 4Recruiting
Effects of GH and Lirglutide on AgRP
Liraglutide
- NCT06842758N/AActive Not Recruiting
Relationship Between Thoracic Hyperkyphosis and Fall Risk in Women with Fragility Vertebral Fractures
Teriparatide
- NCT05835089N/AUnknown
Evaluation of Some Puberty-related Hormones Among Children and Adolescents With Chronic Kidney Diseases
Kisspeptin
- NCT05856630Phase 1Unknown
Pharmacokinetics Pharmacodynamics and Safety of LY01022 in Patients With Prostate Cancer Compared With Zoladex® 10.8mg
Gonadorelin
- NCT05870462Phase 4Unknown
Semaglutide and Vascular Regeneration
Semaglutide
- NCT05760313Phase 2Completed
A Study to Assess Adverse Events and Change in Disease Activity in Pediatric Participants (Age 6 Months to <2 Years) With Functional Constipation Who Are Treated With Linaclotide
Linaclotide
- NCT05841238Phase 1Completed
A Multiple Dose Study of LY3502970 in Healthy Overweight and Obese Participants
Orforglipron
- NCT05774756Phase 3Active Not Recruiting
A Trial of Setmelanotide in Acquired Hypothalamic Obesity
Setmelanotide
- NCT05268237Phase 1/Phase 2Recruiting
Safety, Tolerability and Preliminary Efficacy of Sublingual Liraglutide in Patients With Type 2 Diabetes Mellitus
Liraglutide
- NCT05822544Phase 1Active Not Recruiting
Phase 1/1b Study of TLC-6740 in Healthy Subjects and Subjects With Obesity, With or Without Diabetes
Tirzepatide
- NCT05822830Phase 3Completed
A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight With Weight Related Comorbidities
Tirzepatide
- NCT05804513Phase 4Unknown
The Effect of Lixisenatide on the Effect of Pituitary Hormones
Lixisenatide
- NCT05630586Phase 2Recruiting
Acute Subcutaneous SemaglutidE in Acute Ischemic sTroke
Semaglutide
- NCT05804162Phase 1Completed
A Research Study Looking at How Cagrilintide Works on the Heart Rhythm in Healthy Participants
Cagrilintide
- NCT05482789Phase 4Recruiting
Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes
Exenatide
- NCT05555589Phase 3Recruiting
Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2
TB-500
- NCT05751226Phase 1Completed
A Study in People With Overweight or Obesity to Test How Well Different Doses of BI 1820237 Are Tolerated When Given Alone or in Combination With Either Semaglutide or BI 456906
Semaglutide
- NCT05815680Phase 1Completed
A Study to Evaluate the Drug-drug Interactions (DDIs) of IBI362 With Metformin, Warfarin, Atorvastatin, Digoxin in Overweight or Obese Subjects
Mazdutide
- NCT05564104Phase 1Completed
A Research Study Looking at How a Single Dose of the Medicine Cagrilintide Works in Participants With Reduced Liver Function and in Healthy Participants With Normal Liver Function and How Cagrilintide is Absorbed and Used by the Body
Cagrilintide
- NCT05810597Phase 1Completed
A Research Study Looking at Similarity Between Tirzepatide Versions for Different Injection Devices
Tirzepatide
- NCT05813925Phase 3Completed
A Research Study to See How Well CagriSema Helps People in East Asia With Excess Body Weight Lose Weight
Semaglutide
- NCT05794906Phase 3Active Not Recruiting
A Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) and Placebo Given With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local Therapies
Gonadorelin
- NCT05803421Phase 3Completed
A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk
Orforglipron
- NCT05786521Phase 4Completed
Effect of GLP1 Receptor Agonists on Physical Function, Body Composition, and Markers of Aging in Older Adults
Semaglutide
- NCT05390307N/ACompleted
Obesity Treatment to Improve Diabetes
Semaglutide
- NCT05790447Phase 2Unknown
Thymalfasin-based PRaG Mode for Advanced Refractory Solid Tumors
Thymosin-Alpha-1
- NCT05521828N/AUnknown
Luteal Phase Ovarian Stimulation With Follitropin Delta and Dydrogesterone
Thymosin-Alpha-1
- NCT05328258Phase 3Recruiting
Use of GnRHa During Chemotherapy for Fertility Protection
Gonadorelin
- NCT06827002Phase 1/Phase 2Active Not Recruiting
Effect of Aqueous Extracts of Cissus Quadrangularis and Dichrostachys Glomerata on GLP-1 Concentration and DPP-4 Activity in Overweight and Obese Adults
Semaglutide
- NCT05746806N/AActive Not Recruiting
Trial of Ultrahypofractionated Focal Salvage Radiotherapy for Isolated Prostate Bed Recurrence After Radical Prostatectomy
Gonadorelin
- NCT05854784Phase 2Completed
Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Variegate Porphyria (VP)
Afamelanotide
- NCT05359146EARLY_Phase 1Unknown
Combined Beta- Plus Auger Electron Therapy Using a Novel Somatostatin Receptor Subtype 2 Antagonist Labelled With Terbium-161 (161Tb-DOTA-LM3)
Octreotide
- NCT05794581Phase 1Completed
A Study to Assess the Effects of CT-868 Treatment on Glucose Homeostasis in Participants with Type 1 Diabetes
Liraglutide
- NCT05757531Phase 1Completed
A Study of Carbon-14-Labelled [14C] LY3437943 in Healthy Male Participants
Retatrutide
- NCT05441267Phase 4Active Not Recruiting
A Study of Cardiovascular Events iN Diabetes Plus
Semaglutide
- NCT05443568N/ACompleted
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Israel, as Part of Local Clinical Practice
Semaglutide
- NCT05706506Phase 4Completed
A Study of Tirzepatide (LY3298176) in Adults With Type 2 Diabetes Switching From a GLP-1 RA (SURPASS-SWITCH-2)
Tirzepatide
- NCT05169112Phase 3Recruiting
Impact of Hormonal Therapy on Prostate Cancer Recurrence After Radical Prostatectomy
Gonadorelin
- NCT05766709Phase 1Completed
A Research Study Comparing Blood Levels of Medicines NNC0194-0499 and Semaglutide Administered as a Combination Formulation Versus Two Separate Formulations
Semaglutide
- NCT05761431Phase 1Completed
A Single-dose Study of Octreotide Injection in Healthy Adult Subjects
Octreotide
- NCT05669755Phase 3Active Not Recruiting
REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels
Semaglutide
- NCT05713578EARLY_Phase 1Recruiting
Efficacy and Safety of Apantamide Combined With Docetaxel and ADT vs. Apantamide Combined With ADT in Patients With High Tumor Burden mHSPC: a Multicenter and Prospective Cohort Study
Gonadorelin
- NCT05502562N/ACompleted
A Research Study to Understand How Oral Semaglutide Works in People With Type 2 Diabetes in India
Semaglutide
- NCT05346848Phase 2Recruiting
Randomized Phase II Trial on Short Term Darolutamide Concomitant to Radiation Therapy for Patients With Intermediate Unfavorable Risk Prostate Cancer
Gonadorelin